The relaxant effects of alfentanil and remifentanil on noradrenaline-treated rat aorta

Pain Clinic

Volumn 15, Issue 3, 2003, Pages 321-325

  Tuncer, Sema ^a   Bariskaner, Hulagu ^a   Dogan, Necdet ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Alfentanil; Rat thoracic aorta; Remifentanil

Indexed keywords

ALFENTANIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLIBENCLAMIDE; INDOMETACIN; NALOXONE; NARCOTIC ANTAGONIST; NORADRENALIN; OPIATE; POTASSIUM CHANNEL BLOCKING AGENT; PROPRANOLOL; PROSTAGLANDIN SYNTHASE INHIBITOR; REMIFENTANIL; TETRYLAMMONIUM;

ANALGESIA; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BLOOD VESSEL TONE; CARDIOVASCULAR EFFECT; DRUG EFFECT; MALE; NONHUMAN; RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

EID: 0141680404     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856903767650862     Document Type: Article

References (14)

1. Holaday JW, Cardiovascular effects of endogenous opiate systems, Annu Rev Pharmacol 23, 541-6 (1983).
2. Johnson MW, Mitch WE, Wilcox CS, The cardiovascular actions of morphine and endogenous opioid peptides, Prog Cardiovasc Dis 27, 435-7 (1985).
3. Klockgether-Rodke AP, Gravemann J, Kettler D, et al., Influence opioids on the vascular tone of isolated porcine coronary artery segments, Acta Anaesthesiol Scand 44, 1134-7 (2000).
4. Monitto CL, Kurth CD, The effect of fentanyl, sufentanil and alfentanil on cerebral arterioles in piglets, Anesth Analg 76, 985-9 (1993).
5. Hanouz JL, Yvon A, Guesne G, et al., The in vitro effects of remifentanil, sufentanil, fentanyl and alfentanil on isolated human right atria. Anesth Analg 93, 543-9 (2001).
6. Karasawa F, Iwanov V, Moulds RF, Sufentanil and alfentanil cause vasorelaxation by mechanisms independent of the endothelium, Clin Exp Pharmacol Physiol 20, 705-11 (1993).
7. White DA, Reitan JA, Kien ND, et al., Decrease in vascular resistance in the isolated canine hindlimb after graded doses of alfentanil, fentanyl and sufentanil, Anesth Analg 71, 29-34 (1990).
8. Harder DR, Madden JA, Cellular mechanisms of opiate receptor stimulation in cat middle cerebral artery, Eur J Pharmacol 102, 411-6 (1984).
9. El Sharkawy TY, Al-Shireida MF, Pilcher CTW, Vascular effects of some opioid receptor agonists, Can J Physiol Pharmacol 69, 846-9 (1991).
10. Parra L, Vizcaino FP, Alsasua A, et al., Mu and delta opioid receptor mediated contractile effects on rat aortic vascular smooth muscle, Eur J Pharmacol 277, 99-105 (1995).
11. Zhang CC, Judy YS, Calkins D, Effects of alfentanil on isolated cardiac tissues of the rabbit, Anesth Analg 71, 268-74 (1990).
12. Kazmaier S, Hanekop GG, Buhre W, et al., Myocardial consequences of remifentanil in patients with coronary artery disease, Br JAnaesth 84, 578-83 (2000).
13. Hoffman WE, Cunningham F, James MK, et al., Effects of remifentanil, a new short-acting opioid on cerebral blood flow, brain electrical activity and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide, Anesthesiology 79, 107-13, discussion 26A (1993).
14. Lorenz IH, Kolbitsch C, Schocke M, et al., Low-dose remifentanil increases regional cerebral blood flow regional cerebral blood volume, but decreases regional mean transit time and regional cerebrovascular resistance in volunteers, Br J Anaesth 85 199-204 (2000).